Mounjaro 3 Month Supply in the UK: A Practical Guide

Step 1: What three months of Mounjaro actually looks like week by week

Mounjaro comes as a pre-filled KwikPen, and each pen delivers one dose a week for four weeks. A three-month tirzepatide supply therefore means three pens, covering twelve consecutive weekly injections. That sounds straightforward, but the months are rarely identical to each other.

The first pen is almost always the 2.5 mg starter dose. Its job is to let your system adjust gradually, keeping nausea and other gastrointestinal effects manageable, rather than targeting the full therapeutic range from day one. Your prescriber will then decide whether to step up after those four weeks. For many people, month two brings the 5 mg pen; month three may mean 7.5 mg or staying at 5 mg if that's the right pace for you. The decision belongs to your prescriber, not to a protocol you follow independently.

This titration pattern is why thinking of a three-month supply as "three of the same pen" is the most common misconception about how the medicine works. You're very likely collecting pens of increasing strength, which means your pharmacy needs to have the right dose in stock at the right moment, something worth confirming a week or so before you need each one. Our guide to Mounjaro supply issues in the UK covers what to do if your dose isn't immediately available.

Step 2: What clinical review looks like at each repeat

Because tirzepatide is a prescription-only medicine, no repeat can be dispensed without a prescriber reassessing your case. At nume (at our GPhC-registered pharmacy) a GPhC-registered Independent Prescriber reads your updated answers personally before each new pen is approved. A real clinician reviews it, not an automated queue.

That review matters practically. A prescriber checks that your weight loss is progressing as expected, that side effects are within a tolerable range, and that a dose increase is appropriate or whether staying at the current level serves you better. NICE's appraisal of tirzepatide (TA1026) also specifies that continuing treatment should be reassessed if less than five percent of body weight has been lost after six months at the highest tolerated dose. Your prescriber will flag that at the right point.

For people sourcing treatment from elsewhere, it's worth understanding what that repeat review should look like, and asking questions if it feels perfunctory. A brief online tick-box with no clinical contact is not the same thing. More on how to evaluate any online provider is on our FAQ page.

Step 3: Planning supply across three months, stock, timing and cost context

UK availability of Mounjaro has fluctuated since the medicine was licensed here, with higher doses sometimes harder to obtain than starter pens. If you want to understand the broader picture before you begin, our overview of Mounjaro supply in the UK explains how availability has shifted and what that means for planning ahead. A pharmacy cannot guarantee a specific dose weeks in advance, and any service that does should give you pause.

Cost is a reasonable thing to think about when planning a three-month supply. Eli Lilly raised Mounjaro's UK list price in September 2025, and higher doses now carry higher list prices, typically ranging from roughly £149 to £375 per pen depending on dose and provider, according to widely reported figures. You'll find a clear breakdown of how those figures work, and what a legitimate price includes, on our Mounjaro cost in the UK page. The short version: a legitimate price covers clinical assessment, the prescription itself, and dispensing, not just the pen.

Timing matters too. If you order by midday on a working day and your prescription is clinically approved, dispatch happens the same day, with free tracked delivery arriving the next working day. Building that rhythm into your calendar (rather than waiting until you've used your last dose) means you're unlikely to face a gap between pens. Read more about how a continuous three-month Mounjaro course fits into longer treatment planning.

What to keep in mind through months one to three

The NHS's patient information for tirzepatide (NHS medicines: tirzepatide) is worth reading before you start and revisiting as your dose changes. Side effects are most noticeable in the days after starting or increasing a dose, nausea, loose stools, and indigestion are the most common. They tend to ease as your body adjusts, usually within a week or two, and slowing the pace of titration can help if they don't.

A few practical points for the three-month stretch: store each pen in the fridge between 2 and 8°C; the Patient Information Leaflet sets out the exact window if you need to take it out temporarily, and that's the right source rather than any summary. Rotate your injection sites (abdomen, thigh and upper arm are all licensed) to avoid skin changes building up in one spot. And if you're using oral contraceptives, discuss with your prescriber whether a barrier method is advisable for the first four weeks of treatment and after any dose increase, because tirzepatide's effect on gastric emptying may affect pill absorption.

If anything feels wrong during treatment (particularly severe, persistent stomach pain that radiates to the back) seek medical attention promptly rather than waiting for your next review. Our clinical team is also reachable seven days a week for aftercare queries. You can find more detail about what the medicine is and how it works on our tirzepatide overview, which also touches on tirzepatide supply considerations worth reviewing if you want to understand availability before committing to a course, or explore broader weight-loss treatment options if you're still deciding where to start.